home / stock / sprc / sprc news

SPRC News and Press, SciSparc Ltd. From 04/11/24

Stock Information
Company Name: SciSparc Ltd.
Stock Symbol: SPRC
Market: NASDAQ
Menu
SPRC SPRC Quote SPRC Short SPRC News SPRC Articles SPRC Message Board
Get SPRC Alerts

News, Short Squeeze, Breakout and More Instantly...
SPRC - SciSparc to Acquire AutoMax

TEL AVIV, Israel, April 11, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that it signe...
SPRC - SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression

TEL AVIV, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that as part ...

SPRC - SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research

MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 21, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the develo...

SPRC - TLRY, ACB and CGC are among pre market gainers

2024-03-18 07:44:53 ET More on premarket gainers & stock. Tilray: Big Opportunities Ahead In Germany And Alcohol Segment Aurora Cannabis: Barely Surviving Or Soon To Be Thriving? Canopy Growth Corporation (CGC) Q3 2024 Earnings Call Transcript Tilray wins...
SPRC - SciSparc Granted Another Patent, Strengthening its Core Technology in Canada

TEL AVIV, Israel, March 18, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, t...

SPRC - SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial

First patient has been dosed in the randomized, controlled, double blind clinical trial for Autism Spectrum Disorder in pediatric patients TEL AVIV, Israel, March 14, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmace...

SPRC - SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure

MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 12, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the develo...
SPRC - Samsara, DocuSign, Gap among premarket gainers' pack

2024-03-08 08:30:06 ET Ainos ( AIMD ) +147% . Psyence Biomedical ( PBM ) +104% . CERo Therapeutics ( CERO ) +47% . Gulf Island Fabrication ( GIFI ) +27% on Q4 earnings release . Recruiter.com ( RCRT ) +17% . Porch Group ( P...

SPRC - SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder

TEL AVIV, Israel, March 08, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that the first patient has been...

SPRC - Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation

2024-03-07 11:29:12 ET More on Clearmind Medicine, Bright Minds, etc. Mind Medicine (MindMed) Inc. (MNMD) Q4 2023 Earnings Call Transcript Mind Medicine: Positive MM-120 Data Leads To Other 2024 Catalysts De-Risking Psychedelics: Compass Pathways, Cybin And Atai ...
Previous 10 Next 10